Skip to main content

Drug Addiction

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
2 programs
Continuing Care Telephone SupportN/A1 trial
FEM-CAREN/A1 trial
Active Trials
NCT00744068Completed302Est. Sep 2011
NCT02258425Completed130Est. Nov 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Angeles TherapeuticsFEM-CARE
Angeles TherapeuticsContinuing Care Telephone Support

Clinical Trials (2)

Total enrollment: 432 patients across 2 trials

Homeless Female Offenders Returning to the Community

Start: Jan 2015Est. completion: Nov 2016130 patients
N/ACompleted
NCT00744068Angeles TherapeuticsContinuing Care Telephone Support

Four Models of Telephone Support for Stimulant Recovery

Start: Apr 2006Est. completion: Sep 2011302 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.